May 2019

Optogenerapy > 2019 > May

Optogenerapy partner GeneXplain has built a mathematical model to further improve and optimize the optogenetic pathway of Optogenerapy’s medical device. The model, which allows to predict the behaviour of the cells involved in the production of IFN- β drug for patients suffering from multiple sclerosis, can simulate different scenarios, helping to explore the system without spending resources on experiments.   In this interview, Kamilya Altynbekova, software developer...

Read More